(Q53587646)

15 May 2018

title

Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. (English)

1 reference

15 May 2018

9

Nahum Sonenberg

1 reference

15 May 2018

10

Eleanor N Fish

1 reference

15 May 2018

Surinder Kaur

1

1 reference

15 May 2018

Lakhvir Lal

2

1 reference

15 May 2018

Antonella Sassano

3

1 reference

15 May 2018

Beata Majchrzak-Kita

4

1 reference

15 May 2018

Maya Srikanth

5

1 reference

15 May 2018

Darren P Baker

6

1 reference

15 May 2018

Emmanuel Petroulakis

7

1 reference

15 May 2018

Nissim Hay

8

1 reference

15 May 2018

Leonidas C Platanias

11

1 reference

15 May 2018

language of work or name

English

0 references

publication date

17 November 2006

1 reference

15 May 2018

Journal of Biological Chemistry

published in

1 reference

15 May 2018

volume

282

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

1757-1768

1 reference

15 May 2018

Interferons and their actions

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Signaling pathways activated by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferons: mechanisms of action and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The current status of antiviral therapy of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Therapeutic role of beta-interferons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The PI3' kinase pathway in interferon signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Activation of protein kinase C delta by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Protein kinase Cdelta regulates apoptosis via activation of STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Activation of the p38 mitogen-activated protein kinase by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Role of p38alpha Map kinase in Type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The p38 mitogen-activated protein kinase pathway in interferon signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Protein ISGylation modulates the JAK-STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Will mTOR inhibitors make it as cancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Translational control in stress and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Regulation of cap-dependent translation by eIF4E inhibitory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

ISG15: the immunological kin of ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The p38 mitogen-activated protein kinase pathway and its role in interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

A new pathway of translational regulation mediated by eukaryotic initiation factor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Small ISGs coming forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Dysregulation of the TSC-mTOR pathway in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

PI3K/Akt/mTOR pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607365200

21 January 2018

Identifiers

DOI

10.1074/JBC.M607365200

1 reference

15 May 2018

1 reference

15 May 2018